Market uncertain, but these 10 stocks surge up to 80% i...
Despite a 12.5% Sensex decline in 2026, ten mid-cap stocks have defied the downturn, delivering 37% to 83% gains, showcasing resil...
Gold’s Glittering Vindication
Key Takeaways Over the first quarter of the 21st century (2000–2025), gold rose by 1,486.6%, significantly outperforming major sto...
Delta’s stock soars after a well-timed earnings report ...
Delta had better-than-expected earnings reported after the Iran cease-fire was announced.
Exxon and Shell reveal production hit from Iran war
Integrated oil majors Exxon Mobil and Shell each revealed how the Iran war hurt production in the first quarter.
The price Americans pay for medicine has gotten horribl...
We can start with laws that limit the power of pharmacy-benefit managers
The new high dose of Wegovy costs less than Zepbound
Novo Nordisk launched the high dose version of its GLP-1 injection at a price that’s $50 cheaper than Eli Lilly’s competing drug.
Markets looking ‘through the noise’ of Iran war — but k...
There is still a lot of negotiating ahead, with conflicting demands from Washington and Tehran, according to the analysts
The cease-fire mirage: Here’s why stock-market bulls ma...
Goldman Sachs senior trader sees limited upside for U.S. stocks after the cease-fire between the U.S. and Iran.
The New York Times says it’s identified Satoshi, the in...
A report in The New York Times claims to have identified the person who goes by the pseudonym Satoshi Nakamato, the inventor of bi...
We’re in our 70s with no heirs. I like donating $30,000...
“Our income — Social Security, his VA disability and three pensions — covers all expenses.”
